Industry: Medical Devices & Consumables
Published Date: 2024-06-11
Pages: 111 Pages
Report ld: 3193794
Request Sample
Customized Report
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
The goal of heart failure device treatment is to intervene in these three functional disorders. This usually includes repairing or improving heart structure through anatomical means, using electrophysiological techniques to manage arrhythmias, or enhancing myocardial contractility through mechanical support to improve the heart's pumping function. At the same time, since most heart failures start with left ventricular dysfunction, causing pulmonary congestion, heart failure patients may also experience respiratory failure. Therefore, mechanical support devices can also assist respiratory function and help relieve heart failure symptoms.
According to the treatment principle of the device, the existing heart failure devices on the market can be divided into three categories: mechanical assistance, electrical-related technology and structural improvement. In the future, with the influence of factors such as doctor recognition, accelerated population aging and improved affordability, the market for heart failure devices will further expand.
The global market for Implantable Heart Failure Devices was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
North American market for Implantable Heart Failure Devices was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Implantable Heart Failure Devices was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Implantable Heart Failure Devices was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Implantable Heart Failure Devices include Abbott, Medtronic, Jarvik Heart, Abiomed, Boston Scientific, Impulse Dynamics, SynCardia, Berlin Heart, Covia Medica, V-Wave, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Implantable Heart Failure Devices, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Implantable Heart Failure Devices by region & country, by Type, and by Application.
The Implantable Heart Failure Devices market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Implantable Heart Failure Devices.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Implantable Heart Failure Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Implantable Heart Failure Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Implantable Heart Failure Devices in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Implantable Heart Failure Devices Product Introduction
1.2 Global Implantable Heart Failure Devices Market Size Forecast
1.2.1 Global Implantable Heart Failure Devices Sales Value (2019-2030)
1.2.2 Global Implantable Heart Failure Devices Sales Volume (2019-2030)
1.2.3 Global Implantable Heart Failure Devices Sales Price (2019-2030)
1.3 Implantable Heart Failure Devices Market Trends & Drivers
1.3.1 Implantable Heart Failure Devices Industry Trends
1.3.2 Implantable Heart Failure Devices Market Drivers & Opportunity
1.3.3 Implantable Heart Failure Devices Market Challenges
1.3.4 Implantable Heart Failure Devices Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Implantable Heart Failure Devices Players Revenue Ranking (2023)
2.2 Global Implantable Heart Failure Devices Revenue by Company (2019-2024)
2.3 Global Implantable Heart Failure Devices Players Sales Volume Ranking (2023)
2.4 Global Implantable Heart Failure Devices Sales Volume by Company Players (2019-2024)
2.5 Global Implantable Heart Failure Devices Average Price by Company (2019-2024)
2.6 Key Manufacturers Implantable Heart Failure Devices Manufacturing Base and Headquarters
2.7 Key Manufacturers Implantable Heart Failure Devices Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Implantable Heart Failure Devices
2.9 Implantable Heart Failure Devices Market Competitive Analysis
2.9.1 Implantable Heart Failure Devices Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Implantable Heart Failure Devices Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Implantable Heart Failure Devices as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Mechanical Assistance Type
3.1.2 Electrical Related Technology
3.1.3 Structural Improvement Type
3.2 Global Implantable Heart Failure Devices Sales Value by Type
3.2.1 Global Implantable Heart Failure Devices Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Implantable Heart Failure Devices Sales Value, by Type (2019-2030)
3.2.3 Global Implantable Heart Failure Devices Sales Value, by Type (%) (2019-2030)
3.3 Global Implantable Heart Failure Devices Sales Volume by Type
3.3.1 Global Implantable Heart Failure Devices Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Implantable Heart Failure Devices Sales Volume, by Type (2019-2030)
3.3.3 Global Implantable Heart Failure Devices Sales Volume, by Type (%) (2019-2030)
3.4 Global Implantable Heart Failure Devices Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 GradeⅠ- Ⅳ
4.1.2 Grade Ⅱ- Ⅳ
4.1.3 Grade Ⅲ -IV
4.2 Global Implantable Heart Failure Devices Sales Value by Application
4.2.1 Global Implantable Heart Failure Devices Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Implantable Heart Failure Devices Sales Value, by Application (2019-2030)
4.2.3 Global Implantable Heart Failure Devices Sales Value, by Application (%) (2019-2030)
4.3 Global Implantable Heart Failure Devices Sales Volume by Application
4.3.1 Global Implantable Heart Failure Devices Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Implantable Heart Failure Devices Sales Volume, by Application (2019-2030)
4.3.3 Global Implantable Heart Failure Devices Sales Volume, by Application (%) (2019-2030)
4.4 Global Implantable Heart Failure Devices Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Implantable Heart Failure Devices Sales Value by Region
5.1.1 Global Implantable Heart Failure Devices Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Implantable Heart Failure Devices Sales Value by Region (2019-2024)
5.1.3 Global Implantable Heart Failure Devices Sales Value by Region (2025-2030)
5.1.4 Global Implantable Heart Failure Devices Sales Value by Region (%), (2019-2030)
5.2 Global Implantable Heart Failure Devices Sales Volume by Region
5.2.1 Global Implantable Heart Failure Devices Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Implantable Heart Failure Devices Sales Volume by Region (2019-2024)
5.2.3 Global Implantable Heart Failure Devices Sales Volume by Region (2025-2030)
5.2.4 Global Implantable Heart Failure Devices Sales Volume by Region (%), (2019-2030)
5.3 Global Implantable Heart Failure Devices Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Implantable Heart Failure Devices Sales Value, 2019-2030
5.4.2 North America Implantable Heart Failure Devices Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Implantable Heart Failure Devices Sales Value, 2019-2030
5.5.2 Europe Implantable Heart Failure Devices Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Implantable Heart Failure Devices Sales Value, 2019-2030
5.6.2 Asia Pacific Implantable Heart Failure Devices Sales Value by Region (%), 2023 VS 2030
5.7 South America
5.7.1 South America Implantable Heart Failure Devices Sales Value, 2019-2030
5.7.2 South America Implantable Heart Failure Devices Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Implantable Heart Failure Devices Sales Value, 2019-2030
5.8.2 Middle East & Africa Implantable Heart Failure Devices Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Implantable Heart Failure Devices Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Implantable Heart Failure Devices Sales Value
6.2.1 Key Countries/Regions Implantable Heart Failure Devices Sales Value, 2019-2030
6.2.2 Key Countries/Regions Implantable Heart Failure Devices Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Implantable Heart Failure Devices Sales Value, 2019-2030
6.3.2 United States Implantable Heart Failure Devices Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Implantable Heart Failure Devices Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Implantable Heart Failure Devices Sales Value, 2019-2030
6.4.2 Europe Implantable Heart Failure Devices Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Implantable Heart Failure Devices Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Implantable Heart Failure Devices Sales Value, 2019-2030
6.5.2 China Implantable Heart Failure Devices Sales Value by Type (%), 2023 VS 2030
6.5.3 China Implantable Heart Failure Devices Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Implantable Heart Failure Devices Sales Value, 2019-2030
6.6.2 Japan Implantable Heart Failure Devices Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Implantable Heart Failure Devices Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Implantable Heart Failure Devices Sales Value, 2019-2030
6.7.2 South Korea Implantable Heart Failure Devices Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Implantable Heart Failure Devices Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Implantable Heart Failure Devices Sales Value, 2019-2030
6.8.2 Southeast Asia Implantable Heart Failure Devices Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Implantable Heart Failure Devices Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Implantable Heart Failure Devices Sales Value, 2019-2030
6.9.2 India Implantable Heart Failure Devices Sales Value by Type (%), 2023 VS 2030
6.9.3 India Implantable Heart Failure Devices Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Company Information
7.1.2 Abbott Introduction and Business Overview
7.1.3 Abbott Implantable Heart Failure Devices Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Abbott Implantable Heart Failure Devices Product Offerings
7.1.5 Abbott Recent Development
7.2 Medtronic
7.2.1 Medtronic Company Information
7.2.2 Medtronic Introduction and Business Overview
7.2.3 Medtronic Implantable Heart Failure Devices Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Medtronic Implantable Heart Failure Devices Product Offerings
7.2.5 Medtronic Recent Development
7.3 Jarvik Heart
7.3.1 Jarvik Heart Company Information
7.3.2 Jarvik Heart Introduction and Business Overview
7.3.3 Jarvik Heart Implantable Heart Failure Devices Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Jarvik Heart Implantable Heart Failure Devices Product Offerings
7.3.5 Jarvik Heart Recent Development
7.4 Abiomed
7.4.1 Abiomed Company Information
7.4.2 Abiomed Introduction and Business Overview
7.4.3 Abiomed Implantable Heart Failure Devices Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Abiomed Implantable Heart Failure Devices Product Offerings
7.4.5 Abiomed Recent Development
7.5 Boston Scientific
7.5.1 Boston Scientific Company Information
7.5.2 Boston Scientific Introduction and Business Overview
7.5.3 Boston Scientific Implantable Heart Failure Devices Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Boston Scientific Implantable Heart Failure Devices Product Offerings
7.5.5 Boston Scientific Recent Development
7.6 Impulse Dynamics
7.6.1 Impulse Dynamics Company Information
7.6.2 Impulse Dynamics Introduction and Business Overview
7.6.3 Impulse Dynamics Implantable Heart Failure Devices Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Impulse Dynamics Implantable Heart Failure Devices Product Offerings
7.6.5 Impulse Dynamics Recent Development
7.7 SynCardia
7.7.1 SynCardia Company Information
7.7.2 SynCardia Introduction and Business Overview
7.7.3 SynCardia Implantable Heart Failure Devices Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 SynCardia Implantable Heart Failure Devices Product Offerings
7.7.5 SynCardia Recent Development
7.8 Berlin Heart
7.8.1 Berlin Heart Company Information
7.8.2 Berlin Heart Introduction and Business Overview
7.8.3 Berlin Heart Implantable Heart Failure Devices Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Berlin Heart Implantable Heart Failure Devices Product Offerings
7.8.5 Berlin Heart Recent Development
7.9 Covia Medica
7.9.1 Covia Medica Company Information
7.9.2 Covia Medica Introduction and Business Overview
7.9.3 Covia Medica Implantable Heart Failure Devices Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Covia Medica Implantable Heart Failure Devices Product Offerings
7.9.5 Covia Medica Recent Development
7.10 V-Wave
7.10.1 V-Wave Company Information
7.10.2 V-Wave Introduction and Business Overview
7.10.3 V-Wave Implantable Heart Failure Devices Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 V-Wave Implantable Heart Failure Devices Product Offerings
7.10.5 V-Wave Recent Development
7.11 Evaheart
7.11.1 Evaheart Company Information
7.11.2 Evaheart Introduction and Business Overview
7.11.3 Evaheart Implantable Heart Failure Devices Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Evaheart Implantable Heart Failure Devices Product Offerings
7.11.5 Evaheart Recent Development
7.12 BrioHealth Solutions
7.12.1 BrioHealth Solutions Company Information
7.12.2 BrioHealth Solutions Introduction and Business Overview
7.12.3 BrioHealth Solutions Implantable Heart Failure Devices Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 BrioHealth Solutions Implantable Heart Failure Devices Product Offerings
7.12.5 BrioHealth Solutions Recent Development
7.13 Hanyu Medical
7.13.1 Hanyu Medical Company Information
7.13.2 Hanyu Medical Introduction and Business Overview
7.13.3 Hanyu Medical Implantable Heart Failure Devices Sales, Revenue, Price and Gross Margin (2019-2024)
7.13.4 Hanyu Medical Implantable Heart Failure Devices Product Offerings
7.13.5 Hanyu Medical Recent Development
7.14 NewMed Medical
7.14.1 NewMed Medical Company Information
7.14.2 NewMed Medical Introduction and Business Overview
7.14.3 NewMed Medical Implantable Heart Failure Devices Sales, Revenue, Price and Gross Margin (2019-2024)
7.14.4 NewMed Medical Implantable Heart Failure Devices Product Offerings
7.14.5 NewMed Medical Recent Development
7.15 Valgen Medtech
7.15.1 Valgen Medtech Company Information
7.15.2 Valgen Medtech Introduction and Business Overview
7.15.3 Valgen Medtech Implantable Heart Failure Devices Sales, Revenue, Price and Gross Margin (2019-2024)
7.15.4 Valgen Medtech Implantable Heart Failure Devices Product Offerings
7.15.5 Valgen Medtech Recent Development
8 Industry Chain Analysis
8.1 Implantable Heart Failure Devices Industrial Chain
8.2 Implantable Heart Failure Devices Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Implantable Heart Failure Devices Sales Model
8.5.2 Sales Channel
8.5.3 Implantable Heart Failure Devices Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Implantable Heart Failure Devices market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-27
Pages: 159
USD 4900.00
(Single User License)
The global Implantable Heart Failure Devices market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-27
Pages: 92
USD 4250.00
(Single User License)
The global market for Implantable Heart Failure Devices was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 119
USD 3950.00
(Single User License)
The global Implantable Heart Failure Devices market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-15
Pages: 120
USD 2900.00
(Single User License)
The global Implantable Heart Failure Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 153
USD 4900.00
(Single User License)
The global Implantable Heart Failure Devices market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 91
USD 4250.00
(Single User License)
The global market for Implantable Heart Failure Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 117
USD 3950.00
(Single User License)
The global market for Implantable Heart Failure Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 96
USD 2900.00
(Single User License)
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
Published Date: 2024-06-11
Pages: 135
USD 4350.00
(Single User License)
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
Published Date: 2024-06-11
Pages: 92
USD 2900.00
(Single User License)
The global Implantable Heart Failure Devices market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-27
Pages: 159
The global Implantable Heart Failure Devices market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-27
Pages: 92
The global market for Implantable Heart Failure Devices was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 119
The global Implantable Heart Failure Devices market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-15
Pages: 120
The global Implantable Heart Failure Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 153
The global Implantable Heart Failure Devices market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 91
The global market for Implantable Heart Failure Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 117
The global market for Implantable Heart Failure Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 96
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
Published: 2024-06-11
Pages: 135
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
Published: 2024-06-11
Pages: 92
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now